Published in Z Gesamte Inn Med on August 15, 1977
Renal replacement therapy in an era of socioeconomic changes--report from the Polish Registry. Nephrol Dial Transplant (1997) 1.39
The influence of propranolol on functional alterations of the electrocardiogram. Cardiologia (1968) 0.93
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. J Psychopharmacol (2008) 0.86
[Usefulness of the Michigan Alcoholism Screening Test (MAST) in Poland]. Psychiatr Pol (1986) 0.84
Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder. J Psychopharmacol (2009) 0.83
Controlled delivery of antimicrobial gallium ions from phosphate-based glasses. Acta Biomater (2008) 0.82
Surface characteristics and microbial adherence ability of modified polymethylmethacrylate by fluoridated glass fillers. Aust Dent J (2014) 0.82
[Tumor necrosis factor (TNF) and interleukin-6 (IL-6) in patients with glomerulonephritis]. Pol Arch Med Wewn (1996) 0.81
Vitreoretinal surgery in diabetic patients on hemodialysis. Eur J Ophthalmol (1998) 0.78
Antibiotic eluting clay mineral (Laponite®) for wound healing application: an in vitro study. J Mater Sci Mater Med (2014) 0.75
[Evaluation of a single infusion of low-molecular dextran in patients with chronic obliterative arterial diseases]. Pol Tyg Lek (1969) 0.75
[Ustimon (ST 7090) in the treatment of coronary disease]. Wiad Lek (1967) 0.75
[Case of ascites during treatment with repeated dialysis]. Pol Arch Med Wewn (1978) 0.75
[AIDS-phobia as a symptom or psychopathologic syndrome]. Wiad Lek (1988) 0.75
[Protein polyacrylamide gel electrophoresis and level of neuraminic acids in cerebrospinal fluid in schizophrenics]. Pol Tyg Lek (1974) 0.75
[Results of 2-year use of the immunosuppressive drugs dipyridamole and methindol in the treatment of patients with chronic mesangiocapillary glomerulonephritis]. Pol Tyg Lek (1987) 0.75
[Clinical study of the action of thioridazine-retard Polfa]. Psychiatr Pol (1972) 0.75
[Combined treatment with hydrazinophthalazines and beta sympatholytic agents of nephrogenic hypertension]. Pol Tyg Lek (1976) 0.75
[Case of unusual orientation abilities (inborn capacity for localization of magnetic north pole)]. Psychiatr Pol (1982) 0.75
[Use of ultrasound for evaluating structural changes of the renal parenchyma in chronic primary glomerulopathies]. Pol Tyg Lek (1990) 0.75
[Immune complexes and C3 and C4 of the complement in urine of patients with glomerulonephritis]. Pol Arch Med Wewn (1996) 0.75
[Ultrasound in parenchymatous diseases of the kidney]. Pol Tyg Lek (1989) 0.75
[20 episodes of acute non-inflammatory renal failure in acquired hemolytic anemia]. Pol Arch Med Wewn (1982) 0.75
[Sorbonit in the treatment of coronary disease]. Wiad Lek (1968) 0.75
[Behavior of lipids in schizophrenics]. Pol Tyg Lek (1975) 0.75
[Metabolism of magnesium and lipid disturbances in chronic renal failure]. Pol Arch Med Wewn (1997) 0.75
[Arteriovenous fistulas for hemodialysis in patients with chronic renal failure]. Pol Przegl Chir (1977) 0.75
[Use of the low-molecular dextran for the treatment of thrombophlebitis]. Pol Przegl Chir (1969) 0.75
[Anti-neutrophil cytoplasmic antibodies (ANCA) in the glomerulonephritis]. Pol Arch Med Wewn (1996) 0.75
[Problems of the medical secret in forensic psychiatric certification - on the basis of analyses of 150 forensic psychiatric expert's opinions issued in penal cases (author's transl)]. Psychiatr Pol (1982) 0.75
A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases. Drug Deliv Transl Res (2014) 0.75
[Results of two year use of dipyridamole and metindol in patients with primary focal and (or) segmental glomerulosclerosis]. Pol Merkur Lekarski (1997) 0.75
[Use of microcomputer technic in the hemodialysis department]. Pol Tyg Lek (1989) 0.75